Liposomes as an ocular delivery system for fluconazole: In-vivo study

Bulletin of Pharmaceutical Sciences

Volumn 31, Issue PART 2, 2008, Pages 249-263

  Habib, F S ^a   Fouad, E A ^a   Abdel Rahman, M S ^b   Fathalla, Dina ^a  

^a Assiut University   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CHOLESTEROL; DICETYL PHOSPHATE; FLUCONAZOLE; LIPOSOME; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE;

CANDIDA; DRUG DELIVERY SYSTEM; EVAPORATION; EYE; HEALING; IN VIVO STUDY; KERATITIS; MODEL; RABBIT; SOYBEAN; ULCER HEALING; WEIGHT;

EID: 77953188801     PISSN: 11100052     EISSN: None     Source Type: Journal    
DOI: 10.21608/bfsa.2008.64327     Document Type: Article

References (28)

1. I. P. Kaur, A. Garg, A. K. Singla and D. Aggarwal, Int. J. Pharm., 269, 1 (2004).
2. W. Behrens- Baumann, B. Klinge and R. Ruchel, Br. J. Ophthalmol., 74, 40 (1990).
3. A. Panda, N. Sharma and S. K. Angra, Cornea, 15, 373 (1996).
4. W. Schreiber, A. Olbrisch, C. K. Vorwerk, W. KÖnig and W. Behrens-Baumann, Invest. Ophthalmol. Vis. Sci., 44, 2634 (2003).
5. S. F. Urbak and T. Degn, Opthalmlogica, 208, 147 (1994).
6. D. S. Burgess, R. W. Hastings, K. K. Summers, T. C. Hardin and M. G. Rinaldi, Diagnostic Microbiology and Infectious Disease, 36, 13 (2000).
7. th ed., 1996, pp 1175-1188.
8. P. Sandven, A. Bjomeklett and A. Maeland, Antimicrob. Agents Chemother., 37, 2443 (1993).
9. E. M. Johnson, D. W. Warnock, J. Luker, S. R. Porter and C. Scully, J. Antimicrob. Chemother., 35,103 (1995).
10. M. F. Price, M. T. LaRocco and L. O. Gentry, Antimicrob. Agents Chemother., 38, 422 (1994).
11. A. Ambrosini, G. D. Bossi, G. Dubinib, L. leone, M. Bossi and G. Zolese, Chemistry and Physics of Lipids, 95, 37 (1998).
12. J. Faergeman, J. Godleski, H. Laufen and R. H. Liss, Acta Derm. Veneorol. (Stockh), 75, 361 (1995).
13. R. W. Yee, S. M. Cheng, T. M. Ludden, J. E. Wallace and M. G. RinaldL, Cornea, 16, 64 (1997).
14. O. E. Abbasoglu, B. M. Hosal, B. Sener, N. Erdemoglu and E. Gursel, Exp. Eye Res., 72, 147 (2001).
15. O. N. El-Gazayerly and A. H. Hikal, Int. J. Pharm., 158, 121 (1997).
16. K. Singh and M. Mezei, ibid., 19, 263 (1984).
17. D. Meisner, J. Pringle and M. Mezei, ibid., 55, 105 (1989).
18. F. Suzoka and D. Papahadjopoulos, Proc. Natl. Acad. Sci., USA 75, 4194 (1978).
19. A. Bhatia, J. Pharm. Sci., 7, 252 (2004).
20. R. Agarwal and O. P. Katare, Pharmaceutical Technology, Nov. 2, 48 (2002).
21. W. Schreiber, A. Olbrisch, C. K. Vorwerk, W. KÖnig and W. Behrens-Baumann, Invest. Ophthalmol. Vis. Sci., 44, 2634 (2003).
22. W. Behrens-Baumann, Dev. Ophthalmol., 32, 27 (1999).
23. A. K. Al-Hussains, A. El-Shanawany, E. A. Daef and M. M. Abd El-Latif, Bull. Ophthalmol Soc. Egypt., 90, 809 (1997).
24. W. Behrens- Baumann, B. Klinge and R. Ruchel, Br. J. Ophthalmol., 74, 40 (1990).
25. A. Panda, N. Sharma and S. K. Angra, Cornea, 15, 373 (1996).
26. D. Goldblum, B. E. Frueh, G. Sarra, K. Katsoulis and S. Zimmerli, Antimicrob. Agents and Chemotherapy, 49, 1359 (2005).
27. A. Bochot, E. Fattal, J. L. Grossiord, F. Puisieux and P. Couvreur, Int. J. Pharm., 162, 119 (1998).
28. Y. K. Oh, D. E. Nix and R. M. Straubinger, Antimicrob. Agents Chemother., 9, 2104 (1995).